This review highlights the role of genetic variations, particularly single nucleotide polymorphisms, in determining the risk of cardiovascular disease among dialysis patients.
No takes yet. Share an insight, caveat, or question.
May support SNP-informed CVD risk stratification in dialysis; leaves open clinical utility pending prospective validation.
Rao et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: